Nuveen Asset Management, LLC Catalyst Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $454,407 - $590,729	-110,831 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $151,286 - $219,412	30,687 Added 38.29%	110,831 $559,000
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $13,895 - $22,263	3,054 Added 3.96%	80,144 $505,000
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $289,858 - $617,490	77,090 New	77,090 $453,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.